Eurofins Scientific SE Concludes Share Repurchase

Eurofins Scientific SE, the global leader in bioanalytical testing, reported on its share repurchase activities for the week of November 17 to 21, 2025. Over the course of five days, the company acquired a total of 105,000 of its own shares. The total transaction was completed on the Euronext Paris exchange, under the market identifier code XPAR.

Each daily transaction consisted of 20,000 shares, except the final day, which saw 25,000 shares purchased. The daily weighted average purchase prices ranged from €57.7048 to €58.7743, leading to an overall average price of €57.9165 per share.

This purchasing exercise complies with Article 5(1)(b) of Regulation (EU) N° 596/2014, also known as the Market Abuse Regulation. For full details and individual trades, stakeholders can visit Eurofins Scientific SE's investor relations page.